Drug profile · INN
givosiran sodium
GIVLAARI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
givosiran sodium (GIVLAARI) is an FDA-listed pharmaceutical active ingredient. Associated with Alnylam Netherlands B.V.. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN givosiran sodium
Brand GIVLAARI
Route SUBCUTANEOUS
Formulation SOLUTION
Originator Alnylam Netherlands B.V.
Frequently asked questions
What is givosiran sodium?
givosiran sodium (GIVLAARI) is an FDA-listed pharmaceutical active ingredient. Associated with Alnylam Netherlands B.V.. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for givosiran sodium?
GIVLAARI is a marketed brand name for givosiran sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of givosiran sodium?
givosiran sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.